Executive officer

Michael J. LaBarre

Former Senior Vice President, Chief Technical Officer·Halozyme Therapeutics, Inc.

About

Michael J. LaBarre served as Senior Vice President, Chief Technical Officer of Halozyme Therapeutics. On March 17, 2025, he notified the Company of his decision to retire, effective March 17, 2025, after many years of service and contributions to the Company's ENHANZE drug delivery technology.

Also at Halozyme Therapeutics, Inc.

HT Helen I. Torley President and Chief Executive Officer; Director JH Jeffrey W. Henderson Board Chair; Director BC Bernadette Connaughton Director MP Matthew L. Posard Director BD Barbara Duncan Director MK Mahesh Krishnan Director

Roles

Organization Role Dates Details
Halozyme Therapeutics, Inc. Former Senior Vice President, Chief Technical Officer Present Current role
Paramount BioSciences Vice President of Product Development
Biogen Idec (IDEC) Research and development positions 1995-2006

Related

Company Halozyme Therapeutics, Inc. Company hub Person Helen I. Torley President and Chief Executive Officer; Director Person Jeffrey W. Henderson Board Chair; Director Person Bernadette Connaughton Director Person Matthew L. Posard Director Person Barbara Duncan Director Person Mahesh Krishnan Director Person James Lang Director Person Moni Miyashita Director Person Nicole LaBrosse Senior Vice President, Chief Financial Officer Person Mark Snyder Senior Vice President, Chief Legal Officer Person Cortney Caudill Senior Vice President, Chief Operating Officer Deal Halozyme Therapeutics Antares Pharma 2022 Deal page Deal Halozyme Therapeutics Elektrofi 2025 Deal page
Source: Halozyme Therapeutics, Inc. SEC filings and official company website

See how VectorShift works for your firm

Request Demo